Adrenal response to corticotrophin and testosterone during long-term therapy with itraconazole in patients with chromoblastomycosis.
暂无分享,去创建一个
[1] R. Negroni,et al. Itraconazole: pharmacokinetics and indications. , 1993, Archives of medical research.
[2] F. Queiroz-Telles,et al. ITRACONAZOLE IN THE TREAMENT OF CHROMOBLASTOMYCOSIS DUE TO FONSECAEA PEDROSOI , 1992, International journal of dermatology.
[3] S. Clissold,et al. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. , 1990, Drugs.
[4] R. M. Tucker,et al. Adverse events associated with itraconazole in 189 patients on chronic therapy. , 1990, The Journal of antimicrobial chemotherapy.
[5] J. Cutsem. The In‐vitro Antifungal Spectrum of Itraconazole , 1989 .
[6] J. Cutsem. Oral, Topical and Parenteral Antifungal Treatment with Itraconazole in Normal and in Immunocompromised Animals , 1989 .
[7] J. Dunn,et al. Adrenal response to corticotropin during therapy with itraconazole , 1987, Antimicrobial Agents and Chemotherapy.
[8] J. Heykants,et al. Itraconazole: pharmacologic studies in animals and humans. , 1987, Reviews of infectious diseases.
[9] D. Feldman,et al. Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. , 1986, Endocrine reviews.
[10] P. Marichal,et al. Cytochrome p‐450: Target for itraconazole , 1986 .